Authors
Latest:
Ultra-widefield imaging: A critical step in uveitis diagnosis and managementA multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Latest:
Q&A: The increasing potential of ERG in diagnosing a wide range of eye conditionsEasier, more accessible functional studies have been made possible
Latest:
Geographic atrophy treatment: High attrition rates challenge long-term patient adherenceTwo FDA-approved geographic atrophy treatments show significant patient dropout, with 45% discontinuation by 18 months, driven by baseline vision, CNV, and lack of immediate visual improvement.
Latest:
Humanity + technology: Talking to patients about the science and benefits of clinical trialsWhen we discuss trial participation with patients, we stress that the goal of these studies is to obtain better visual outcomes and ease the treatment burden.
Latest:
The unique role of the retina optometristZhang’s journey as the first retina optometrist in Colorado
Latest:
Case 3: Achieving Rapid Fluid Resolution in nAMD With FaricimabA panelist discusses how a woman aged 77 years with bilateral neovascular age-related macular degeneration (nAMD) demonstrated different responses to treatments between her eyes, showing a superior response to faricimab in her right eye compared with ranibizumab, highlighting how some patients may respond better to specific anti-VEGF agents.
Latest:
COVID-19 pandemic highlights the power of electronic health recordsElectronic health records may be the future of practice management.
Latest:
A short-term sustained-release insert can offset treatment burdenLooking at innovative tools and their applications in different disease states can help to think creatively about ways to benefit patients in retina care.
Latest:
Drugs to treat GA: Yes, please!Patients are highly motivated to slow disease progression with GA drugs and healthy lifestyle.
Latest:
How remote retinal imaging raises the bar across service, research and educationBaljean Dhillon, FRCPS, FRCS, FRCOphth, FRCPE, advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium.
Latest:
Subretinal drusenoid deposits: Marker for unrecognized cardiac diseaseNew research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need for ophthalmologists to screen patients effectively.
Latest:
Emerging insights into ocular immune-related diseases and treatment optionsIn this study, researchers examine immune mechanisms in ocular diseases like uveitis, AMD, DR, and GO, highlighting microglial roles, targeted therapies, and promising advances in immunotherapy.
Latest:
Faricimab improves vision for minority patients with diabetic macular edemaStudy reveals faricimab effectively treats diabetic macular edema in underrepresented minorities, showing significant visual acuity improvements and safety across diverse patient populations.
Latest:
Retina World Congress: Global innovations transforming treatment strategiesInternational retina specialists converge to explore groundbreaking treatments, drug delivery systems, and surgical innovations at the Retina World Congress 2025.
Latest:
High-resolution multimodal imaging is key in dry AMD therapeutic development, future managementIn an attempt to halt the progression of dry AMD and geographic atrophy, the use of high-resolution optical coherence tomography becomes pivotal.
Latest:
Effectiveness Of Pegcetacoplan In Preserving Visual Function In Geographic AtrophyDr Charles Wykoff presents the results of a post hoc microperimetry analysis from the OAKS study demonstrating the effectiveness of pegcetacoplan in preserving visual function.
Latest:
Wet AMD therapeutics: Technologies raising the ceiling for functional visual outcomesNeovascular macular degeneration is multifactorial, which requires future agents to target multiple pathways.
Latest:
Where might AI be heading?A look at the current state of AI in diabetic eye disease and where the future may take us.
Latest:
AAO 2024: Bonnie An Henderson, MD, explores future of medical education in Kelman LectureHenderson’s presentation touches on the shift in medical education from traditional learning to AI and robotics.
Latest:
Clinical Implications of Port Delivery System in Retinal DiseasesClosing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Latest:
How remote retinal imaging raises the bar across service, research and educationBaljean Dhillon, FRCPS, FRCS, FRCOphth, FRCPE, advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium.
Latest:
Vitrectomy: Is higher speed always better?Physicians should consider hydrodynamic cavitation when performing this procedure.
Latest:
Poll: Most anticipated emerging therapies in neovascular AMD and DMEA panel of retina specialists review new and emerging treatments in neovascular AMD and DME, highlighting high-dose aflibercept and KSI-301. Which emerging treatments are you most interested in?
Latest:
Pearls for maintaining quality, safety in retina clinics amid a pandemicTo maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimize clinic visits and maximize the use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximizing safety and patients’ vision outcomes.
Latest:
Case 2: Management of Progressive Geographic Atrophy in an 84-Year-Old ManFerhina S. Ali, MD, MPH, discusses the management of progressive geographic atrophy in an 84-year-old man, focusing on the significance of patient education in optimizing treatment outcomes and adherence.
Latest:
Ocugen’s IND amendment to begin phase 2/3 confirmatory trial of OCU410ST cleared by FDAThe phase 2/3 clinical trial for OCU410ST will enroll 51 participants diagnosed with Stargardt disease.
Latest:
Setting a New Standard in Automated Tracked PerimetryInnovative new features build on the benefits of the iCare COMPASS Automated Perimeter
Latest:
OSN New York Retina 2024: Understanding how next-generation anti-VEGFs perform in real-world settings compared to trialsFerhina S. Ali, MD, discussed the real-world efficacy and durability of next-generation anti-VEGF agents like faricimab and aflibercept 8 mg, emphasizing how large-scale data offers insights into their performance and safety beyond clinical trials.
